
The FDA has granted accelerated approval for Seattle Genetics and Astellas Pharma’s bladder cancer drug Padcev (enfortumab vedotin-ejfv). The drug’s …

The FDA has approved Pfizer and Astellas Pharma’s Xtandi (enzalutamide) to treat patients with a type of prostate cancer. The …

Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department. McGarvey will be …

Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. McLellan is to be …

Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

